Back to Top

"One of today's leaders in investor relations and shareholder services"

Tag Archives: VTEQ

VeriTeQ Corporation and Establishment Labs to Host Physician Conference in Europe Based on Demand for Motiva Breast Implants With Q Inside Safety Technology

DELRAY BEACH, Fla., Oct. 15, 2014 (GLOBE NEWSWIRE) — VeriTeQ Corporation (“VeriTeQ” or “Company”) (OTC Markets:VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that the Company and its breast implant customer, Establishment Labs, S.A., (“EL”) are hosting a physician conference in Salzburg, Austria on October 16, 2014, based on demand for EL’s Motiva Implant Matrix® breast implants with VeriTeQ’s Q Inside Safety Technology™.

As of mid-September, more than 1,000 women in Europe, Latin America and Asia have now received Motiva Implant Matrix® breast implants with Q Inside Safety Technology™. EL’s Motiva Implant Matrix® Ergonomix™, VelvetSurface® PLUS, and SilkSurface® PLUS, all with VeriTeQ’s Q Inside Safety Technology™, have received CE Mark approval.

VeriTeQ’s FDA cleared Q Inside Safety Technology™ acts as an electronic serial number in breast implants and other implantable and reusable medical devices to provide physicians and patients access to secure online …

Continue Reading

Posted in Client News| Tagged |

VeriTeQ Corporation Enters Agreement Providing Exclusive License of Multiple Patents From NC State University

DELRAY BEACH, Fla., Oct. 9, 2014 (GLOBE NEWSWIRE) — VeriTeQ Corporation (“VeriTeQ” or “Company”) (OTC Markets:VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that it has entered an agreement providing an exclusive license of multiple patents from North Carolina State University (“NCSU”). VeriTeQ will license 24 patents, which are the foundation for its FDA cleared Q Inside SmartMarker and OneDose products for radiation dosimetry.

Q Inside SmartMarker (formerly known as DVS SmartMarker) is an implantable radiation sensor for use in breast and prostate cancer patients undergoing photon external beam treatments. It is implanted in, or adjacent to, solid-mass tumors and gathers data on the actual dose of radiation being delivered to the tumor and surrounding normal tissue. Q Inside SmartMarker is intended to be used in the balancing between delivering maximum dose to the tumor while minimizing the impact to healthy tissue. The …

Continue Reading

Posted in Client News| Tagged |

VeriTeQ Receives First Order for 100 Units of Its New Q Inside Readers for Breast Implants

DELRAY BEACH, Fla., Sept. 29, 2014 (GLOBE NEWSWIRE) — VeriTeQ Corporation (“VeriTeQ”) (OTC Markets:VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that it has received an order for 100 units of its new Q Inside readers for breast implants. The Q Inside reader identifies VeriTeQ’s Q Inside Safety Technology within breast implants and other medical devices.

VeriTeQ recently announced the launch of its new readers, the Q Inside Reader + and the Q Inside Reader XR +, which identify its Q Inside Safety Technology™ micro-transponders used for unique medical device identification. VeriTeQ’s FDA cleared Q Inside Safety Technology™ acts as an electronic serial number in breast implants and other implantable and reusable medical devices to provide physicians and patients access to secure online databases to retrieve device-specific data, such as serial number, manufacturer name, date of manufacture, lot number, volume, size, and other …

Continue Reading

Posted in Client News| Tagged |

Photo Release — VeriTeQ Unveils New Q Inside Safety Technology Readers for Medical Device Identification

VeriTeQ unveils its new Q Inside Reader + for accurate identification of implanted medical devices.

VeriTeQ Launches New Readers Based on Demand From Breast Implant Industry

DELRAY BEACH, Fla., Sept. 18, 2014 (GLOBE NEWSWIRE) — VeriTeQ Corporation (“VeriTeQ”) (OTC Markets:VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that it has unveiled two new readers used to identify VeriTeQ’s Q Inside Safety Technology™ within implantable medical devices: the Q Inside Reader + and the Q Inside Reader XR +. The new readers are being launched based on demand from the breast implant industry.

A photo accompanying this release is available at http://www.globenewswire.com/newsroom/prs/?pkgid=27730

The readers will identify VeriTeQ’s Q Inside Safety Technology micro-transponders used for unique medical device identification. The Q Inside Reader + is Bluetooth-enabled and comes complete with a USB lead for charging the reader’s internal rechargeable battery. The Q Inside Reader XR + is also Bluetooth-enabled and has an extended read-range.

VeriTeQ’s FDA cleared Q Inside Safety …

Continue Reading

Posted in Client News| Tagged |

Over 1,000 Women Worldwide Have Now Received Motiva Breast Implants with VeriTeQ’s Q Inside Safety Technology

Geographic adoption continues in Europe, Latin America and Asia

September 16, 2014 09:39 AM Eastern Daylight Time

DELRAY BEACH, Fla.–(BUSINESS WIRE)–VeriTeQ Corporation (“VeriTeQ”) (OTC Markets: VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that more than 1,000 women worldwide have now received Motiva Implant Matrix® breast implants with VeriTeQ’s Q Inside Safety Technology™. Motiva Implant Matrix® breast implants, manufactured by Establishment Labs S.A. (“EL”), featuring VeriTeQ’s Q Inside Safety Technology™ can be safely and accurately identified from outside of the body in a physician’s office.

VeriTeQ’s FDA cleared Q Inside Safety Technology™ acts as an electronic serial number in breast implants and other implantable and reusable medical devices to provide physicians and patients access to secure online databases to retrieve device-specific data, such as serial number, manufacturer name, date of manufacture, lot number, volume, size, and other data from the medical device manufacturer. …

Continue Reading

Posted in Client News| Tagged |

VeriTeQ Corporation to Host Conference Call to Update Investors on Business and other Recent Events

Call will take place on Wednesday, September 3, 2014 at 10 am ET

August 26, 2014 08:30 AM Eastern Daylight Time

DELRAY BEACH, Fla.–(BUSINESS WIRE)–VeriTeQ Corporation (“VeriTeQ”) (OTC Markets: VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that it will host a conference call on Wednesday, September 3, 2014, at 10 a.m. ET, to update investors on the business and other recent events.

Interested participants should call (800) 219-3192 within the United States or (617) 597-5412 internationally, and use passcode 71640596#.

For those unable to participate in the conference call, a replay will be available on September 3, 2014 at 11:59 p.m. ET for seven days. For the replay, dial (888) 286-8010 within the United States or (617) 801-6888 internationally, and use passcode 57571260.

About VeriTeQ

VeriTeQ develops innovative, proprietary RFID technologies for implantable medical device identification, and dosimeter technologies for use in …

Continue Reading

Posted in Client News| Tagged |